Heat Biologics has devised a method intended to capture poly-antigens and present them to immunomodulatory mechanisms and revitalize the immune system, allowing it to target and annihilate cancer.
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Optimizing an extracellular matrix scaffold for ovarian follicle implantation helps create successful bioprosthesis for restoring fertility in sterile mice.